Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms

Mod Pathol. 2024 Apr;37(4):100441. doi: 10.1016/j.modpat.2024.100441. Epub 2024 Feb 2.

Abstract

We review B-cell neoplasms in the 5th edition of the World Health Organization classification of hematolymphoid tumors (WHO-HEM5). The revised classification is based on a multidisciplinary approach including input from pathologists, clinicians, and other experts. The WHO-HEM5 follows a hierarchical structure allowing the use of family (class)-level definitions when defining diagnostic criteria are partially met or a complete investigational workup is not possible. Disease types and subtypes have expanded compared with the WHO revised 4th edition (WHO-HEM4R), mainly because of the expansion in genomic knowledge of these diseases. In this review, we focus on highlighting changes and updates in the classification of B-cell lymphomas, providing a comparison with WHO-HEM4R, and offering guidance on how the new classification can be applied to the diagnosis of B-cell lymphomas in routine practice.

Keywords: B-cell lymphomas; Classification; World Health Organization; fifth edition.

Publication types

  • Review

MeSH terms

  • Hematologic Neoplasms* / pathology
  • Humans
  • Lymphoma, B-Cell* / pathology
  • Pathologists
  • World Health Organization